Grand Rounds March
Center for High Risk Pregnancies Welcomes Dr. Jacques E. Samson

Maternal fetal specialist Dr. Jacques E. Samson has joined UT Medical Group’s Center for High Risk Pregnancies in East Memphis.

Samson earned his medical degree at Meharry Medical College in Nashville. He completed his obstetrics and gynecology residency at Wayne State University in Detroit, where he became an assistant professor. He subsequently completed a fellowship in maternal fetal medicine at the University of Tennessee Health Science Center and currently serves on the faculty as assistant professor of maternal fetal medicine.

 

Acadia Healthcare Announces the Purchase of Delta Medical Center

Acadia Healthcare Company, Inc.(NASDAQ: ACHC) today announced the purchase of Delta Medical Center of Memphis, a 243-bed hospital in Memphis, TN, with the majority of operating beds dedicated to acute inpatient psychiatric patients.

Joey Jacobs, Chairman and Chief Executive Officer of Acadia, said that the purchase of Delta Medical Center represents a great opportunity for Acadia to enter the Memphis market with a high quality facility and an outstanding medical staff. It also gives them the opportunity to treat acute inpatient psychiatric patients with medical complications. They expect the transaction will be accretive to their financial results, and noted that, with a license for 243 total beds, not all of which are currently in operation, the facility has significant capacity for expansion.

 

Church Health Conference: Healthy Communities, Communities Of Faith

 

April 4-7, 2013 • Memphis Marriott and Cook Convention Center, Downtown Memphis, TN

 

For 25 years, the Church Health Center has worked to create a medical home for the uninsured and to promote wellness in and through faith communities – all supported with private funding. Now the Center is convening a diverse gathering of dreamers and doers for the first-ever Church Health Conference, Healthy Communities, Communities of Faith! Learn from those at the Center and from other people who are doing the real work of healing ministry.

Who: Calling all faith community nurses, clergy members, lay health workers, medical and dental professionals, students, chaplains and anyone interested in growing a faith-based clinic.

What: A multi-day conference that includes plenary sessions, workshop tracks, connection opportunities and sharing of best practices, plus in-depth preconference options such as Faith Community

Keynote speaker: Noted author and civil rights leader Ambassador Andrew Young has always viewed his career through the lens of being an ordained minister. His life story and ongoing work for civil and human rights will inspire you to dig deeper and re-commit yourself to doing the real work of ministry in your congregation and community.

The conference will also include two dedicated focus tracks, one for faith community nurses and another for those interested in starting faith-based clinics to serve the uninsured:

Registration is now open for $300. There is an additional fee of $120 for pre-conference workshops. Student registration fees are $240.

For information or to register, visit ChurchHealthCenter.org or call (901) 272-7170, Ext. 2096

 

West Clinic Physicians Join Medical Staff at Crittenden Regional Hospital

 Crittenden Regional Hospital welcomes two new Medical Oncology and Hematology physicians, Moon Fenton, M.D., PhD. and Ronald D. Lawson, M.D., FACP to its medical staff. CRH also congratulates our local Radiation Oncology physician, Loverd M. Peacock, M.D. on joining The West Clinic at their West Memphis office.

Dr. Fenton joins the CRH medical staff as a specialist in Medical Oncology and Hematology. A native Memphian, Dr. Fenton is Board Certified in Medical Oncology. She obtained her Medical Degree from the University of Tennessee Health Science Center. She received a PhD in Molecular Cell Sciences from The University of Memphis and did research at St. Jude Children’s Research Hospital in Hematology. She completed her Internal Medicine Residency at Wayne State University and Fellowship in Hematology and Oncology at the University of Pittsburgh Medical Center, concentrating her research on leukemia and immunology. Dr. Fenton currently serves on the National Comprehension Pain Network® (NCCN) Panel for colorectal cancer and has been approved for an NCCN grant in head and neck cancer research.

Dr. Lawson also joins the CRH medical staff as a specialist in Medical Oncology and Hematology. Dr. Lawson is board-certified in medical oncology by the American Board of Medical Oncology and in internal medicine by the American Board of Internal Medicine. He received his medical degree from the University of Tennessee and completed his internal medicine residency at Methodist Hospital in Memphis, Tennessee. Upon completion of his residency, Dr. Lawson accepted and completed his Medical Oncology Fellowship at the University of Texas System Cancer Center MD Anderson Hospital and Tumor Institute in Houston, Texas. He also completed his Advanced Fellow & Instructor Program through the Department of Developmental Therapeutics at MD Anderson Hospital and Tumor Institute. Dr. Lawson has served patients at The West Clinic for approximately seven years and sees patients at the Midtown and West Memphis Locations.

Dr. Peacock continues to provide radiation oncology for Eastern Arkansas at the new West Clinic location in West Memphis. Dr. Peacock is board-certified in radiation oncology by the American Board of Radiology and in internal medicine by the American Board of Internal Medicine. He brings 35 years of experience in radiation oncology alone, and more than four decades in medicine.

Dr. Peacock earned his medical degree from the University of Arkansas for Medical Sciences. In addition to a preceptorship in tropical medicine in Guatemala, Dr. Peacock completed his internship with University Hospital in Little Rock and his residency in radiation oncology at the University of Utah Medical Center.

Dr. Peacock’s credentials include postdoctoral work in radiobiology/hyperthermia research and numerous academic appointments. He has also been active at the state and national levels in the American College of Radiology (ACR), American Society of Therapeutic Radiology (ASTRO) and American Cancer Society (ACS).

 

Applications Requested for ZeroTo510 Medical Device Accelerator

Applications are now open for ZeroTo510, an entrepreneurship accelerator program designed to help start-ups bring medical device products and services to market.  Applications will be accepted until March 25, 2013.

ZeroTo510 is unique among accelerator programs in that it focuses on medical devices, leveraging the regional strength of the Memphis area.  The goal of ZeroTo510 is to help medical device entrepreneurs navigate the start-up process, refine their business models and achieve the Food and Drug Administration’s 510(k) pre-market notification filing.

Results for the six companies in the inaugural 2012 program were outstanding, with one company, Restore Medical Solutions, completing the program with a full round (Series A) of venture capital funding, and four others finishing the accelerator with additional funding in the amount of $100,000 each.

Through a competitive application process, six companies will again be selected for the 2013 ZeroTo510 Medical Device Accelerator, where they will matriculate through an intensive, mentor-driven, 12-week program of instruction and hands-on activities designed to guide the entrepreneurs through the process. Each company chosen for the program will receive $50,000 in initial seed capital from co-investors Innova, a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the healthcare, technology and healthcare technology fields across the state of Tennessee, and MB Venture Partners, a Memphis-based venture capital firm that provides equity capital and strategic direction to life sciences start-ups.

The program is operated by Memphis Bioworks Foundation, a not-for-profit organization that is leading the collaboration among public, private, academic, and government entities to accelerate the growth of the bioscience industry in the Memphis region, and Innova.  ZeroTo510 is an initiative of the Greater Memphis Regional Accelerator, a program funded by Launch Tennessee and the State of Tennessee as part of Governor Haslam’s INCITE initiative.  Announced in May 2012, the INCITE program is designed to support innovation across the state and drive growth in the creation of knowledge-based jobs. INCITE is named for its focus on innovation, commercialization, investment, technology and entrepreneurship.

An entrepreneurship program for medical devices is an ideal match for the resources and talents of the Memphis area.  Typically, it can take several years for ideas to pass through the traditional FDA regulatory process.  The 510(k) process provides an expedited path to market, and as such makes a good fit for an accelerator program, but achieving success in that path requires unique skills and knowledge.  ZeroTo510 will provide the coaching, mentoring, networking and access to subject matter experts that entrepreneurs need in order to be successful.

At the end of the 12-week program, the participants will pitch to a group of investors. The investors will select finalists, who will receive as much as $100,000 in additional capital infusion and the opportunity to further develop their business.  And, there is always additional funding potential, as demonstrated by last year’s Series A funding for one company, once the presentation round is reached.

Competition for participation in the program is open internationally.  However, companies selected must be based in Memphis for the duration of the program.

Applications to participate in ZeroTo510 are due by March 25.  Companies for participation will be notified by April 11.  The program will begin on May 11.  Information on applying and additional information about the ZeroTo510 program is available at http://www.zeroto510.com.

 

Kevin Spiegel to Leave Methodist

 Kevin M. Spiegel, FACHE, who became the CEO/Administrator of Methodist University Hospital in March, 2008, has accepted a position as the new president and CEO of Chattanooga-based  Erlanger Health Systems.

Since taking on the role as senior vice president and CEO of the hospital, he has ambitiously executed goals to expand the collaboration abilities of the hospital – including garnering an affiliation with Columbia University Medical Center’s Heartsource to establish a Methodist University Hospital cardiothoracic surgery and cardiology quality assurance program.

Methodist has also received center of excellence recognition for stroke and cardiac care, excellence in transplantation, and the robotic surgery program reached its 100th case.

Prior to joining Methodist Healthcare, Spiegel served as president and chief operating officer of Trumbull Memorial Hospital, a 350-bed tertiary hospital in Ohio. Under his leadership, Trumbull Memorial experienced substantial market share growth, implemented an affiliation agreement with the University Hospital’s Ireland Cancer Center for the provision of regional cancer services and earned Solucient’s Top 100 Hospitals ranking in Modern Healthcare.

 

Former State Health Commissioner Joins Regional Medical Center

Susan Cooper, MSN, RN, FAAN, has joined Regional Medical Center in the position of Chief Integration Officer and Senior Vice President of Ambulatory Services.  In this role, Cooper will be instrumental in furthering Regional Medical Center’s mission to improve the health and well-being of the community while focusing on the healthcare delivery model of the future, including a shift from care provided in the hospital to care in the community through a system of ambulatory services to meet the individual’s health needs.

Appointed by Governor Phil Bredesen in 2007, Cooper served as the Commissioner of the Department of Health, State of Tennessee, for five years. In 2011, Cooper transitioned to the Governor’s Office, working on health and wellness related special projects. Before joining state government, Cooper was a faculty member and assistant dean at Vanderbilt’s School of Nursing. Cooper began her career as a nurse specializing in emergency and intensive care. Cooper earned her Bachelor and Master of Science in Nursing at Vanderbilt University School of Nursing and is a Fellow in the American Academy of Nursing.

 

Kosten Run Set March 24

The Kosten Foundation will hold its Kick It 5k run at 2 pm Sunday, March 24, at Shelby Farms Park.  The event, presented by Baptist Memorial Hospitals, benefits the Herb Kosten Pancreatic Cancer Research Foundation.

For more information, call 901-288-7446 or visit info@kostenfoundation.com.

The Kosten Foundation is a collaborative effort between the Herb Kosten Family and the University of Tennessee, Memphis. Inspired by Kosten’s death due to pancreatic disease and the lack of community support and research progress toward this disease, his family initiated a grass-roots fundraising effort in the Memphis community.

 Yearly tennis tournaments have yielded generous funding toward the fight against pancreatic cancer in the Memphis community.

 

Rise in drug costs to hospitals, clinics slowing in 2013

Even though costs for medications will continue to rise in 2013 by as much as 4 percent, the increase is projected to be less than in previous years, according to a report in the advance online publication of the American Journal of Health-System Pharmacy, the journal of the American Society of Health-System Pharmacists (ASHP).

The report, “Projecting Future Drug Expenditures in U.S. Non-Federal Hospitals and Clinics—2013,” looked at drug expenditure trends in 2011 and 2012, projects drug expenditures for 2013 and examines factors likely to influence drug expenditures. Based on a variety of data, including new drug approvals and patent expirations, the authors project a 1–3 percent increase in drug expenditures across all settings, a 2–4 percent increase in expenditures for clinic-administered drugs, and a 1.5 percent increase in hospital drug expenditures for 2013.

In the aggregate, drug expenditure growth is moderating, especially in the hospital setting, according to the report’s principal author, James M. Hoffman, Pharm.D., who is the medication outcomes and safety officer and an associate member in the Pharmaceutical Sciences Department at St. Jude Children’s Research Hospital. But when focusing on specific drugs, such as drugs frequently used in clinics, there are dramatic dramatic increases in expenditures. Cancer therapies in particular stand out as costly drugs for hospitals and clinics, and the paper summarizes the high costs for new oncology agents that came on the market in 2012 and the top 20 antineoplastic drug expenditures in clinics in 2011 and 2012.

The overall rise in drug costs is less than in previous years, according to the authors. The increasing availability of less-expensive generic product is a primary factor reducing drug expenditures.

From September 2011 to September 2012, prescription sales in the U.S. totaled $326 billion, a 0.8 percent increase from the previous 12 months. The growth rate was the lowest in recent history. The authors attribute this slowing to modest increases in expenditures for new products (3.3 percent) and pricing of existing products (5.9 percent), coupled with a marked decline in overall volume and mix (less than 8.4 percent).

Retail pharmacies, mail-order pharmacies and clinics accounted for the majority of prescription expenditures. Oncology medications and biologics continue to be large and important expenditures for hospitals and clinics. Antineoplastic agents were the top medication expenditures in nonfederal hospitals in 2012, accounting for 15.1 percent of all hospital drug expenditures in 2012, while oncology products accounted for 32.2 percent of drug expenditures in clinics during the first nine months of 2012.

 

Mark Williams named surgeon in chief for Le Bonheur Children’s

Pediatric Urologist Mark Williams, MD, FAAP, FACS, has been named the new surgeon in chief for Le Bonheur Children’s Hospital. Williams has practiced at Le Bonheur since 2002 and currently serves as the hospital’s chief of Pediatric Urology.

Williams will represent surgical interests and participate in strategic planning efforts for the hospital. He also will serve on the executive committee of the UT Le Bonheur Pediatric Specialists board.

 Williams serves as associate professor within the Department of Urology at UTHSC. He is program director of the pediatric urology fellowship program for UTHSC and a faculty member of St. Jude Children’s Research Hospital.

Williams graduated from the Medical College of Georgia and completed fellowship training in pediatric urology at UTHSC and Le Bonheur.

Tags:
None
Related: